Appointment Icon

UnityPoint Clinic - Express (Ankeny)

1055 Southwest Oralabor Road
Ankeny, IA 50023

Closed Patients
Waiting Now

UnityPoint Clinic - Express (Jordan Creek)

180 Jordan Creek Pkwy
West Des Moines, IA 50266

Closed Patients
Waiting Now

UnityPoint Clinic - Express (Waukee)

950 E Hickman Rd
Waukee, IA 50263

Closed Patients
Waiting Now

UnityPoint Clinic Behavioral Health Urgent Care - Des Moines

1250 East 9th Street
Des Moines, IA 50316

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Altoona

2720 8th Street Southwest
Altoona, IA 50009

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ankeny Medical Park

3625 North Ankeny Boulevard
Ankeny, IA 50023

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ingersoll

2103 Ingersoll Avenue
Des Moines, IA 50312

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Merle Hay

4020 Merle Hay Road
Des Moines, IA 50310

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Southglen

6520 Southeast 14th Street
Des Moines, IA 50320

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Urbandale

5200 NW 100th Street
Urbandale, IA 50322

Closed Patients
Waiting Now

Ovarian Cancer Screening Trial

Early detection of ovarian cancer greatly increases survival rates. This study will explore if the CA-125 level is an accurate detector of early stage ovarian cancer.

If you are a woman and want to considered for the trial here are the requirements:

- 50 to 75 years of age

- at least one year post-menopausal

- have at least one ovary

- are willing to have blood draw for a CA-125 test at least once a year

- are cancer free, or have been cancer/treatment free for at least 12 months

For more information about the Ovarian Cancer Screening Trial please contact the UnityPoint Health-Des Moines Office of Research at 515-241-6727.


FDA Approved Studies

The Office of Research has been involved with a variety of inpatient and outpatient studies since the office was established over 15 years ago. Many of the drugs and devices studied have received FDA approval. Following are a few of the FDA approved drugs/devices studied at UnityPoint Health:

Havrix™, dabigatran, alvimopan, micafungin, cinacalcet, omalizumab, dimethyl fumarate, telavancin, everolimus, methylnaltrexone, RotaTeq™, Endurant Endograft Stent™, Aimovig and the INCRAFT™ AAA Stent Graft System.

All studies help answer important clinical questions and help lead us down the path to improved healthcare for the patients we serve.